p53 mutation does not affect prognosis in ovarian epithelial malignancies

This publication has 26 references indexed in Scilit:

• INK4a/ARFLocus Alterations in Human Non-Hodgkin's Lymphomas Mainly Occur in Tumors with Wild-Type p53 Gene
  The American Journal of Pathology, 2000
• Cancer phenotype correlates with constitutional TP53 genotype in families with the Li–Fraumeni syndrome
  Oncogene, 1998
• Quantification of p53 in Epithelial Ovarian Cancer
  Gynecologic Oncology, 1997
• Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer
  New England Journal of Medicine, 1996
• p53 Status and the Efficacy of Cancer Therapy in Vivo
  Science, 1994
• p53 Gene Mutation in Human Borderline Epithelial Ovarian Tumors
  JNCI: Journal of the National Cancer Institute, 1994
• P53 mutation in a series of epithelial ovarian cancers from the U.K., and its prognostic significance
  European Journal of Cancer, 1994
• p53, guardian of the genome
  Nature, 1992
• Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6
  Nature, 1991
• Adjuvant Therapy in Stage I and Stage II Epithelial Ovarian Cancer
  New England Journal of Medicine, 1990